Funding opportunity from the Office of Research. Bridge Fund Award applications will be accepted until 12/1/25. Go HERE for more information.

Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Trial Not Allowed)

2 months 1 week ago
Funding Opportunity RFA-AG-26-007 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites Cooperative Agreement (U24) applications for the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratory (AITC) Coordinating Center (AITCC). The AITC Program promotes the development and implementation of artificial intelligence approaches and technology through research projects for aging and AD/ADRD research. The central functions of the AITCC are to (1) serve as a hub for the AITC Program and facilitate and coordinate activities across the AITC Program, (2) centralize and lead key stakeholder engagement activities across the AITC Program, and (3) enhance the scientific impact and reach of the AITC Program by actively disseminating information about the program and attracting new researchers from across the country to participate in program activities and resources.

Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional)

2 months 1 week ago
Funding Opportunity RFA-AG-26-006 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites Center Core (P30) applications for the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratories (AITC) program. The AITC Program promotes the development and implementation of artificial intelligence approaches and technology through research projects for aging and AD/ADRD research. All applications should propose strategies for addressing ethical challenges surrounding artificial intelligence and technologydevelopment and implementation, and to employ, when possible, best practices established in the fields of aging and AD/ADRD.

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

2 months 1 week ago
Funding Opportunity PAR-25-446 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption. This NOFO will utilize the UG3/UH3 activity code.

Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)

2 months 1 week ago
Funding Opportunity RFA-AG-26-025 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invitesapplications for the Claude D. Pepper Older Americans Independence Centers (OAICs) award. The goal of the OAIC program is to establishcenters of excellence in geriatrics research and research education to increase scientific knowledge leading to better ways to maintain or restore independence in older persons. OAIC awards are designed to develop or strengthen programs that focus on, and sustain progress in, a key area of aging research related to the mission of the OAIC program.

Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

2 months 2 weeks ago
Funding Opportunity RFA-AI-25-010 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to continue support for a nonhuman primate (NHP) reagent resource that enables rigorous and reproducible research in NHP models through the development, production, and distribution of NHP-specific immunologic reagents that are not commercially available or, if commercially available, are not optimized for use in NHPs. The over-arching goal is to accelerate cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases by facilitating robust preclinical research in NHPs.

Influenza Transmission Research Consortium (P01 Clinical Trial Optional)

2 months 2 weeks ago
Funding Opportunity RFA-AI-25-035 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support basic research to understand the fundamental mechanisms underlying human-to-human transmission of seasonal influenza virus. The NOFO will establish an Influenza Transmission Research Consortium comprised of a network of individual Influenza Transmission Research Centers. Centers should propose collaborative, multidisciplinary teams that will investigate the dynamics and drivers of influenza transmission and develop novel resources to further the field of respiratory virus transmission.

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

2 months 2 weeks ago
Funding Opportunity RFA-AG-26-011 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites R25 applications to support the development and implementation of summer research education programs for high school students, undergraduates, or science teachers from all backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences. It is essential to expand and broaden the skilled Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their careers. The proposed research education programs will support intensive summer research experiences in the AD/ADRD field with the goal of exposing participants to AD/ADRD research and encourage further study or participation in biomedical and behavioral research. This NOFO does not allow participants to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

2 months 2 weeks ago
Funding Opportunity RFA-AG-26-010 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO) invites R25 applications to support the development and implementation of research education programs for recent baccalaureates from all backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences. It is essential to expand and broaden the skilled Alzheimers Disease (AD) and Alzheimers Disease and Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their careers. The proposed research education programs will support intensive research experiences in the AD/ADRD field with the goal of preparing recent baccalaureates to transition into strong, research-focused advanced degree programs or competitive private sector research careers in AD-related disciplines.
Checked
4 hours 12 minutes ago
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Subscribe to NIH Grants feed